 |
|
|
| |
Simeprevir (TMC435) with peginterferon/ribavirin in patients co-infected with chronic genotype-1 HCV and HIV-1: Week-24 interim analysis of the TMC435-C212 study
|
| |
| |
Reported by Jules Levin
CROI Atlanta 2013 Mar 3-6
Douglas Dieterich1, Jurgen Kurt Rockstroh2, Chloe Orkin3, Felix Gutierrez4, Marina B Klein5, Jacques Reynes6, Wolfgang Jessner7, Oliver Lenz7,
Monica Peeters7, Maria Beumont-Mauviel7
1Mount Sinai School of Medicine, New York, NY, USA; 2Department of Medicine I, University of Bonn, Bonn, Germany; 3Royal London Hospital, London, UK; 4Hospital General de Elche and UMH, Alicante, Spain; 5MUHC Montreal Chest Institute, Montreal, Canada; 6Hopital Gui De Chauliac, Montpellier, France; 7Janssen Infectious Diseases BVBA, Beerse, Belgium
|
| |
|
|
|
|
|
